Cancer is an insidious thief. Our goal is to stop that thief in its tracks.
MCCCC combines Children's Cancer Institute, Sydney Children's Hospital, and UNSW researchers in purpose-built facility with 900-capacity workforce. New funding accelerates immunotherapy, liquid biopsy, and precision medicine programs; AI technology reduces diagnostic turnaround from weeks to hours.
- Minderoo Foundation committed additional $3.6 million on opening day, following initial $20 million investment
- Centre integrates Children's Cancer Institute, Sydney Children's Hospital Kids Cancer Centre, and UNSW researchers in single facility
- AI technology expected to reduce precision medicine diagnostic time from 3-4 weeks to days or hours
- Centre can accommodate 900 cancer professionals; includes virtual care for rural and remote areas
Australia's first Children's Comprehensive Cancer Centre opened in Sydney with $3.6 million additional funding from Minderoo Foundation, integrating research, treatment and education to accelerate childhood cancer breakthroughs.
On a May morning in Sydney, Australia opened a building that had been years in the making—the Minderoo Children's Comprehensive Cancer Centre, a facility designed to do something that has long seemed impossible: bring together under one roof the people who treat childhood cancer, the scientists who study it, and the researchers who hunt for new ways to beat it. Dr Andrew Forrest, the philanthropist who helped fund the centre, stood alongside Federal Health Minister Mark Butler and NSW Parliamentary Secretary for Health Dr Michael Holland as the doors opened to what is now Australia's first dedicated cancer facility built specifically for children.
The centre represents a consolidation of existing institutions and expertise. It merges the Children's Cancer Institute with the Kids Cancer Centre at Sydney Children's Hospital in Randwick, and adds researchers from UNSW Sydney into the mix. All of them now work in a single purpose-built space designed not just for efficiency, but for the kind of collaboration that happens when a pediatric oncologist can walk down the hall and talk directly with a molecular biologist about a patient's case. The facility can accommodate 900 professionals—clinicians, scientists, and allied health workers—all working toward the same end.
Minderoo Foundation, the philanthropic vehicle behind much of this, had already invested $20 million to help establish the centre. On opening day, the foundation announced an additional $3.6 million commitment to accelerate specific research programs. That money will fund work in immunotherapy and liquid biopsy technology, which allows doctors to detect cancer through blood tests rather than invasive procedures. It will also strengthen the centre's Zero Childhood Cancer program, which tailors treatment to each patient's genetic makeup, environmental factors, and lifestyle. The precision medicine approach has historically required three to four weeks for doctors to receive actionable information. Artificial intelligence integrated into the diagnostic process is expected to compress that timeline to days, or even hours.
Dr Forrest framed the work in terms that moved beyond the clinical. "Cancer, particularly childhood cancer, is an insidious thief," he said. "Our goal has always been to stop that thief in its tracks and make childhood cancer non-fatal." The language was direct, almost defiant. He described the new facility as a beacon of hope—a phrase that might sound like rhetoric until you consider what it means to a family sitting in an oncology waiting room. The centre's design includes child-friendly inpatient spaces and family-focused amenities. It also includes a virtual care centre, which extends treatment and monitoring to children living in rural and remote parts of Australia, places where specialist pediatric cancer care has historically been unavailable.
Nicola Forrest, Dr Forrest's wife and co-chair of Minderoo Foundation, spoke to the emotional weight of the work. "There is no gift more precious than a child's life," she said, "and nothing more powerful than hope in the face of illness." She emphasized that the centre would serve families at their most vulnerable moment, offering not just treatment but the possibility of survival.
The architecture of the centre itself reflects a deliberate philosophy. The research laboratories, treatment centres, and education facilities are arranged with what the foundation describes as shared spaces designed for connection and collaboration. This is not accidental. The integration of research and clinical care in one building is meant to accelerate the journey from laboratory discovery to patient treatment. When a researcher finds something promising in the lab, the pathway to testing it with actual patients becomes shorter. When a clinician encounters a treatment challenge, the scientist is nearby.
Over the past five years, Minderoo Foundation has committed $134.6 million to cancer research, treatment, and infrastructure. The opening of this centre represents a significant portion of that investment, but also a shift in how the foundation thinks about the problem. Rather than funding individual research projects or isolated treatment programmes, Minderoo has invested in infrastructure—a physical place designed to change how people work together. The bet is that better collaboration, faster information flow, and the integration of cutting-edge technology like artificial intelligence will translate into better outcomes for children with cancer. Whether that bet pays off will become clear over the coming years, as the centre's clinicians and researchers begin to move treatments from the bench to the bedside faster than has been possible before.
Citações Notáveis
Cancer, particularly childhood cancer, is an insidious thief. Our goal has always been to stop that thief in its tracks and make childhood cancer non-fatal.— Dr Andrew Forrest
There is no gift more precious than a child's life, and nothing more powerful than hope in the face of illness.— Nicola Forrest
A Conversa do Hearth Outra perspectiva sobre a história
Why does it matter that all these groups—the researchers, the doctors, the hospital—are now in the same building instead of scattered across Sydney?
Because right now, when a child is diagnosed with cancer, their treatment is often decided by whoever happens to be available at their hospital. But the best treatment might come from research happening somewhere else, or from a specialist who works in a different institution. When everyone is in one place, a doctor treating a patient can immediately consult with the scientist who understands the genetic profile of that particular cancer. That conversation happens in minutes, not weeks.
The announcement mentions artificial intelligence reducing diagnostic time from weeks to hours. That's a dramatic claim. What's actually happening there?
The precision medicine approach requires analyzing a patient's genetic data, environmental factors, and other variables to recommend a tailored treatment. That analysis used to be done manually, which took time. AI can process that same data much faster—looking at patterns across thousands of cases and identifying the most relevant treatment options almost instantly. It's not replacing the doctor's judgment; it's giving the doctor better information, faster.
The centre serves children with cancer. How does a building change what happens to those children?
A building doesn't change anything by itself. But this one is designed so that the people who can help are in the same place. A child in rural Australia can now access care through the virtual centre. A child in Sydney gets treatment informed by research happening in the lab next door. The child-friendly design means the experience is less traumatic. These are small things individually, but together they shift the odds.
Minderoo has now invested over $134 million in cancer research and infrastructure. What's the theory of change—why does a foundation spend that much money on this particular problem?
Because childhood cancer is rare enough that the market won't solve it on its own. Pharmaceutical companies won't invest heavily in treatments for diseases that affect relatively few children. But those children still get sick. A foundation can step in and say: we're going to build the infrastructure, fund the research, and create the conditions for breakthroughs that wouldn't happen otherwise. It's a bet that better tools and better collaboration will save lives.
What happens next? The centre is open—what are people watching for?
Whether the integrated model actually works. Whether having researchers and clinicians in the same building produces faster breakthroughs. Whether the AI tools deliver on their promise. Whether children in rural areas actually use the virtual care centre. And ultimately, whether survival rates for childhood cancer improve. The centre is the infrastructure; the real test is what happens inside it.